Aug 12, 2020 / 08:30PM GMT
Operator
Good afternoon, and welcome to Eton Pharmaceuticals' second-quarter 2020 financial and operating results conference call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
At this time, I'd like to turn the call over to David Krempa, Vice President of Business Development at Eton Pharmaceuticals. Please proceed.
David Krempa - Eton Pharmaceuticals, Inc. - VP, Business Development
Thank you, operator. Good afternoon, everyone, and welcome to Eton's second-quarter 2020 conference call. This afternoon, we issued a press release that outlines the topics we plan to discuss on today's call. The release is available on our website, etonpharma.com.
Joining me on our call today, we have Sean Brynjelsen, our CEO; Wilson Troutman, our CFO; and Paul Stickler, our Senior Vice President of Sales and Marketing.
Before we begin, I would like to remind everyone that statements made during this call may contain [forward-looking] statements and involve risks and uncertainties that could cause actual
Q2 2020 Eton Pharmaceuticals Inc Earnings Call Transcript
Aug 13, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers